Recombinant multi-species BRDT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BRDT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
BRDT is similar to the RING3 protein family. It possesses 2 bromodomain motifs and a PEST sequence (a cluster of proline, glutamic acid, serine, and threonine residues), characteristic of proteins that undergo rapid intracellular degradation. The bromodomain is found in proteins that regulate transcription. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jun 2011]
The Alternative Names of target: 7420412D09Rik,BRD6,BRDT,Brd6,Brdt,Bromodomain testis-specific protein,CT9,Cancer/testis antigen 9 (CT9),Fsrg3,RING3-like protein,SPGF21
Go
to BRDT products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T90985-Ag-1/ GM-Tg-hg-T90985-Ag-2 | Human BRDT protein | Human |
| GM-Tg-rg-T90985-Ag-1/ GM-Tg-rg-T90985-Ag-2 | Rat BRDT protein | Rat |
| GM-Tg-mg-T90985-Ag-1/ GM-Tg-mg-T90985-Ag-2 | Mouse BRDT protein | Mouse |
| GM-Tg-cynog-T90985-Ag-1/ GM-Tg-cynog-T90985-Ag-2 | Cynomolgus/Rhesus macaque BRDT protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T90985-Ag-1/ GM-Tg-felg-T90985-Ag-2 | Feline BRDT protein | Feline |
| GM-Tg-cang-T90985-Ag-1/ GM-Tg-cang-T90985-Ag-2 | Canine BRDT protein | Canine |
| GM-Tg-bovg-T90985-Ag-1/ GM-Tg-bovg-T90985-Ag-2 | Bovine BRDT protein | Bovine |
| GM-Tg-equg-T90985-Ag-1/ GM-Tg-equg-T90985-Ag-2 | Equine BRDT protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T90985-Ag-1/ GM-Tg-hg-T90985-Ag-2;
GM-Tg-rg-T90985-Ag-1/ GM-Tg-rg-T90985-Ag-2;
GM-Tg-mg-T90985-Ag-1/ GM-Tg-mg-T90985-Ag-2; GM-Tg-cynog-T90985-Ag-1/ GM-Tg-cynog-T90985-Ag-2; GM-Tg-felg-T90985-Ag-1/ GM-Tg-felg-T90985-Ag-2; GM-Tg-cang-T90985-Ag-1/ GM-Tg-cang-T90985-Ag-2; GM-Tg-bovg-T90985-Ag-1/ GM-Tg-bovg-T90985-Ag-2; GM-Tg-equg-T90985-Ag-1/ GM-Tg-equg-T90985-Ag-2 |
| Products Name | BRDT protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | BRDT |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BRDT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.